Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids - Wikidata - wikimedia - TriplyDB

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

http://www.wikidata.org/entity/Q57169347

about

Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells

P2860

Q58718475-16FA8238-2882-4541-AB62-DBD53EDED2A4

P2860

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

http://www.wikidata.org/entity/Q57169347

description

article publié dans la revue scientifique Scientific Reports

@fr

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@en

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@nl

type

label

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@en

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@nl

prefLabel

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@en

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@nl

P1433

Q57169347-BF1E7ADA-0CF2-4333-9C5F-5368A83F8A26

P1476

Q57169347-9E710A61-0DA7-4A0F-9BBC-EFFF2453673E

P2093

Q57169347-3CEDB9B4-25BE-4C50-A9F7-7E8B3BF63F46

Q57169347-3FE88551-A27A-4423-B880-8A5CB30C8FB8

Q57169347-5B1A1CCD-24D7-4868-934F-1F3B45F4ECAE

Q57169347-61B5E6C0-34FF-4529-AECC-945BAA00F7D9

Q57169347-6CCCDE9B-9CF6-4CFD-8C7D-913BAE3EFC1E

Q57169347-B318C5C5-D52F-4FD5-8257-42A693698277

Q57169347-B4DA52E3-9D27-4A43-92FB-50F9FF6A47BE

Q57169347-B7FB6DE9-5BF0-48C4-A404-94396771D622

P2860

Q57169347-0BFCCC9A-F482-4C25-9BE6-B8AA5675EE26

Q57169347-1053C931-3365-41A0-B952-62724928CDCC

Q57169347-17261DC4-7684-472F-A9E0-B12658ACBC52

Q57169347-1C7257D4-180B-4BE0-8EBB-6F6E734ADAF8

Q57169347-1E663188-5900-45EA-8B02-C3D93832B74B

Q57169347-26AAEAC2-6F6D-4CDC-9199-411705086533

Q57169347-2A4E7E11-0459-42C6-9D66-6CA9FBC14D2C

Q57169347-2BC36CED-A8F0-4B59-9460-C02ECE1A7738

Q57169347-3515B442-7E10-4E6E-9180-62A054044580

Q57169347-35E61B46-D507-488D-AD77-5CE202FCA177

P304

Q57169347-190DCDBA-E7F1-4F42-AC04-64CAB6690A72

P31

Q57169347-1455A240-2A29-4AED-B265-04CF0EE0A058

P356

Q57169347-D7EDF39B-48E3-40DE-BB7C-B0AC49FE0208

P407

Q57169347-0EF93328-8251-4EB4-8818-4EC4112D3791

P433

Q57169347-92D3CC0A-6298-42A3-BF8D-4BEEF1C1C1A4

P478

Q57169347-EF0ABE25-DEA1-49F2-BF83-5C1C17B234B8

P50

Q57169347-2DFDFDE3-7073-45EA-8233-F55DB332A94A

Q57169347-508716A5-1E3B-474F-9FD1-657F3AB18371

Q57169347-69039F99-6714-4448-8180-B6D46B37BB39

Q57169347-6A11D2D4-D112-420C-BF6B-BA25B737A0BF

Q57169347-6C5B104E-C098-490A-8E05-AA8C6C548BC2

Q57169347-92D3BB3A-6987-442B-B735-6C38F5D79F32

Q57169347-BD40F1C2-B566-4795-9B31-B1E2479385A0

Q57169347-BEEC4AB0-FAC5-4ED1-BC46-9054602CDB22

P577

Q57169347-78B6A484-0254-48E2-9426-48E980D6B3F9

P698

Q57169347-9EA9CFDE-8161-40E5-834A-CF932E017ED3

P932

Q57169347-CB167154-B7C7-4E25-B6A1-1BE6274CE385

P356

S41598-018-30421-W

P1433

Scientific Reports

P1476

Novel monoclonal antibody L2A5 ...... ated by alpha-2-6 sialic acids

@en

P2093

Angelina S Palma

http://www.w3.org/2001/XMLSchema#string

Carina Pereira

http://www.w3.org/2001/XMLSchema#string

Carla B Lopes

http://www.w3.org/2001/XMLSchema#string

Chunxia Li

http://www.w3.org/2001/XMLSchema#string

Dylan Ferreira

http://www.w3.org/2001/XMLSchema#string

Lúcio Lara Santos

http://www.w3.org/2001/XMLSchema#string

Viviana G Correia

http://www.w3.org/2001/XMLSchema#string

Wengang Chai

http://www.w3.org/2001/XMLSchema#string

P2860

Challenges in Antibody Development against Tn and Sialyl-Tn Antigens

Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma

Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms

Siglecs and their roles in the immune system

Glycosylation in cellular mechanisms of health and disease

Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.

Sialyl-tn in cancer: (how) did we miss the target?

A high-throughput O-glycopeptide discovery platform for seromic profiling.

Tumour-associated carbohydrate antigens in breast cancer.

P304

12196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-30421-W

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

José Alexandre Ferreira

Liliana R Loureiro

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30111774

http://www.w3.org/2001/XMLSchema#string

P932

6093877

http://www.w3.org/2001/XMLSchema#string